Ferrarotti Ilaria, Piloni Davide, Filosa Asia, Ottaviani Stefania, Barzon Valentina, Balderacchi Alice Maria, Corda Luciano, Seebacher Christine, Magni Sara, Mariani Francesca, Baderna Paolo, Confalonieri Paola, Iannacci Leonardo, Mancinelli Silvia, Putignano Paola, Albera Carlo, Stella Giulia Maria, Monti Maria Cristina, Corsico Angelo Guido
Centre for Diagnosis of Inherited Alpha-1 Antitrypsin Deficiency, UOC Pulmonology, San Matteo, Pavia, Italy.
Department of Internal Medicine and Therapeutics, Pulmonology Unit, University of Pavia, Pavia, Italy.
Pulmonology. 2025 Dec 31;31(1):2429911. doi: 10.1080/25310429.2024.2429911. Epub 2024 Dec 3.
Alpha-1 Antitrypsin Deficiency (AATD) is a co-dominant condition associated with an increased risk of lung and liver disease. Since it is commonly thought that 95% of severe cases of AATD have PIZZ genotype, most studies about AATD have been focused on the Z variant. Nevertheless, over 500 single nucleotide variations in the gene have been identified. We investigated the clinical presentation of subjects with severe AAT deficiency due to rare genotypes of the gene. We enrolled patients from the Italian Registry for AATD (RIDA1) with the following inclusion criteria: diagnosis of severe AATD; age >18 years; full clinical data available at diagnosis; three years of follow-up respiratory function data. A total of 281 patients were enrolled from the RIDA1 Registry and subdivided into 3 cohorts: PIZZ genotype (n = 160), PISZ genotype (n = 54), and rare genotypes PIR (n = 67). We did not observe any statistical differences among the cohorts regarding sex, smoking habits, occupational exposure and age at diagnosis. Patients with severe AATD due to rare genotypes have clinical characteristics and respiratory profiles similar to PIZZ subjects, and differed from the PISZ patient group. Early and accurate diagnosis of PI*R subjects is therefore important for their appropriate clinical management.
α-1抗胰蛋白酶缺乏症(AATD)是一种共显性疾病,与肺部和肝脏疾病风险增加相关。由于普遍认为95%的严重AATD病例具有PIZZ基因型,因此大多数关于AATD的研究都集中在Z变体上。然而,已在该基因中鉴定出500多个单核苷酸变异。我们调查了因该基因罕见基因型导致严重AAT缺乏的受试者的临床表现。我们从意大利AATD登记处(RIDA1)招募患者,纳入标准如下:诊断为严重AATD;年龄>18岁;诊断时可获得完整临床数据;有三年的随访呼吸功能数据。总共从RIDA1登记处招募了281名患者,并将其分为3个队列:PIZZ基因型(n = 160)、PISZ基因型(n = 54)和罕见基因型PIR(n = 67)。我们未观察到各队列在性别、吸烟习惯、职业暴露和诊断时年龄方面存在任何统计学差异。因罕见基因型导致严重AATD的患者具有与PIZZ受试者相似的临床特征和呼吸特征,与PISZ患者组不同。因此,对PI*R受试者进行早期准确诊断对其适当的临床管理很重要。